Optimizing Exposure Therapy Via Reward-focused Interventions in Individuals With Public Speaking Anxiety
NCT ID: NCT06258889
Last Updated: 2026-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2024-01-08
2024-12-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reward Processing and Exposure Therapy for Social Anxiety Disorder
NCT06776991
Predictors of Exposure Success in Public Speaking Anxiety
NCT02163148
Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety
NCT06564402
Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety
NCT00842946
An Online Large-group One-session Treatment for Public Speaking Anxiety
NCT04790864
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
reward-focused intervention + exposure
Psychoeducation reward-focused interventions based on Positive Affect Treatment (Finding the silver lining, taking ownership, imagining the positive) Exposure \& reward-focused interventions before and after exposure trials
exposure
All participants undergo an exposure training session lasting approximately 90 minutes, which includes three exposure trial where participants give a speech, each lasting 5 minutes.
Exposure exercises are enriched with interventions of the respective treatment group (either reward-focused or cognitive flexibility interventions).
Psychoeducation
All participants received information on anxiety, and the maintenance of anxiety as well as a rationale for the exposure session.
reward-focused intervention
Participants complete three interventions based on the Positive Affect Treatment:
* Finding the silver lining includes attending to and appreciating positive aspects of past events
* Taking ownership includes identifying the personal behavioral contribution to rewarding past experiences
* Imagining the positive includes training the prospective, positive imagination of future events
Participants are asked to practice these interventions at least three times a week (approx. 15 mins each) until the next training session.
Cognitive flexibility intervention + exposure
Psychoeducation Cognitive Flexibility based on Unified Protocol of emotional disorders Exposure \& cognitive flexibility interventions before and after exposure trials
exposure
All participants undergo an exposure training session lasting approximately 90 minutes, which includes three exposure trial where participants give a speech, each lasting 5 minutes.
Exposure exercises are enriched with interventions of the respective treatment group (either reward-focused or cognitive flexibility interventions).
Psychoeducation
All participants received information on anxiety, and the maintenance of anxiety as well as a rationale for the exposure session.
cognitive flexibility intervention
This training aims to promote cognitive flexibility in the context of public speaking situations. The intervention is based on the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders.
Participants will be trained to identify and modify non-adaptive thoughts occurring in the context of public speaking situations.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exposure
All participants undergo an exposure training session lasting approximately 90 minutes, which includes three exposure trial where participants give a speech, each lasting 5 minutes.
Exposure exercises are enriched with interventions of the respective treatment group (either reward-focused or cognitive flexibility interventions).
Psychoeducation
All participants received information on anxiety, and the maintenance of anxiety as well as a rationale for the exposure session.
cognitive flexibility intervention
This training aims to promote cognitive flexibility in the context of public speaking situations. The intervention is based on the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders.
Participants will be trained to identify and modify non-adaptive thoughts occurring in the context of public speaking situations.
reward-focused intervention
Participants complete three interventions based on the Positive Affect Treatment:
* Finding the silver lining includes attending to and appreciating positive aspects of past events
* Taking ownership includes identifying the personal behavioral contribution to rewarding past experiences
* Imagining the positive includes training the prospective, positive imagination of future events
Participants are asked to practice these interventions at least three times a week (approx. 15 mins each) until the next training session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elevated levels of anxiety and avoidance of public speaking situations as indicated by a score of \> 5 and \> 4, respectively, on a scale from 0 to 8 using the following items:
How anxious would you feel giving a formal speech before a live audience? How likely would you be to avoid taking a class that required taking an oral presentation?
Exclusion Criteria
* current psychotherapeutic/psychiatric treatment
* Intention to start psychotherapeutic/psychiatric treatment
* current suicidal ideations
* psychotic symptoms (lifetime)
* current psychopharmacological medication
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philipps University Marburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christoph Benke
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christoph Benke, PhD
Role: PRINCIPAL_INVESTIGATOR
Philipps University Marburg
Anton Regorius, PhD
Role: PRINCIPAL_INVESTIGATOR
Philipps University Marburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Philipps-University Marburg
Marburg, Hesse, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Craske MG, Meuret AE, Ritz T, Treanor M, Dour HJ. Treatment for Anhedonia: A Neuroscience Driven Approach. Depress Anxiety. 2016 Oct;33(10):927-938. doi: 10.1002/da.22490.
Craske MG, Meuret AE, Ritz T, Treanor M, Dour H, Rosenfield D. Positive affect treatment for depression and anxiety: A randomized clinical trial for a core feature of anhedonia. J Consult Clin Psychol. 2019 May;87(5):457-471. doi: 10.1037/ccp0000396.
Barlow DH, Farchione TJ, Bullis JR, Gallagher MW, Murray-Latin H, Sauer-Zavala S, Bentley KH, Thompson-Hollands J, Conklin LR, Boswell JF, Ametaj A, Carl JR, Boettcher HT, Cassiello-Robbins C. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders: A Randomized Clinical Trial. JAMA Psychiatry. 2017 Sep 1;74(9):875-884. doi: 10.1001/jamapsychiatry.2017.2164.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EXOPAT_SPEAKING_ANX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.